Venkataraman Balasubramanian

Array ( [id] => 892187 [patent_doc_number] => 07345034 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-03-18 [patent_title] => 'Azacyclosteroid histamine-3 receptor ligands' [patent_app_type] => utility [patent_app_number] => 11/096382 [patent_app_country] => US [patent_app_date] => 2005-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38550 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/345/07345034.pdf [firstpage_image] =>[orig_patent_app_number] => 11096382 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6945273 [patent_doc_number] => 20050197322 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-08 [patent_title] => 'Compounds capable of binding to proteins constituting or associated with cytoskeletal elements, and their applications for the manufacture of medicaments' [patent_app_type] => utility [patent_app_number] => 11/090072 [patent_app_country] => US [patent_app_date] => 2005-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5643 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20050197322.pdf [firstpage_image] =>[orig_patent_app_number] => 11090072 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5895435 [patent_doc_number] => 20060003974 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-05 [patent_title] => 'Bile acid derived steroidal dimers with amphiphilic topology having antiproliferative activity' [patent_app_type] => utility [patent_app_number] => 11/089451 [patent_app_country] => US [patent_app_date] => 2005-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2136 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20060003974.pdf [firstpage_image] =>[orig_patent_app_number] => 11089451 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7051315 [patent_doc_number] => 20050187202 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-25 [patent_title] => 'Regioselective and stereoselective oxidation of fused ring systems useful for the preparation of aminosterols' [patent_app_type] => utility [patent_app_number] => 11/083961 [patent_app_country] => US [patent_app_date] => 2005-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6179 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20050187202.pdf [firstpage_image] =>[orig_patent_app_number] => 11083961 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5005533 [patent_doc_number] => 20070203105 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-30 [patent_title] => 'Progesterone Receptor Modulators' [patent_app_type] => utility [patent_app_number] => 10/594103 [patent_app_country] => US [patent_app_date] => 2005-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13133 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20070203105.pdf [firstpage_image] =>[orig_patent_app_number] => 10594103 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 263795 [patent_doc_number] => 07569560 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-08-04 [patent_title] => 'Extended cycle multiphasic oral contraceptive method' [patent_app_type] => utility [patent_app_number] => 11/078300 [patent_app_country] => US [patent_app_date] => 2005-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3904 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/569/07569560.pdf [firstpage_image] =>[orig_patent_app_number] => 11078300 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 345135 [patent_doc_number] => 07498322 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-03-03 [patent_title] => 'Antiangiogenic agents' [patent_app_type] => utility [patent_app_number] => 11/077977 [patent_app_country] => US [patent_app_date] => 2005-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15825 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/498/07498322.pdf [firstpage_image] =>[orig_patent_app_number] => 11077977 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7110535 [patent_doc_number] => 20050207990 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-22 [patent_title] => 'Stabilised supersaturated solids of lipophilic drugs' [patent_app_type] => utility [patent_app_number] => 11/076022 [patent_app_country] => US [patent_app_date] => 2005-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6821 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20050207990.pdf [firstpage_image] =>[orig_patent_app_number] => 11076022 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7138180 [patent_doc_number] => 20050182038 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-18 [patent_title] => 'Selective estrogen receptor modulators' [patent_app_type] => utility [patent_app_number] => 11/073087 [patent_app_country] => US [patent_app_date] => 2005-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13994 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20050182038.pdf [firstpage_image] =>[orig_patent_app_number] => 11073087 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7189313 [patent_doc_number] => 20050192450 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-01 [patent_title] => 'Process for the preparation of drospirenone' [patent_app_type] => utility [patent_app_number] => 11/067769 [patent_app_country] => US [patent_app_date] => 2005-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7054 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20050192450.pdf [firstpage_image] =>[orig_patent_app_number] => 11067769 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7256493 [patent_doc_number] => 20050143365 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-30 [patent_title] => 'Structural modification of 19-norprogesterone I: 17-alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents' [patent_app_type] => utility [patent_app_number] => 11/069817 [patent_app_country] => US [patent_app_date] => 2005-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 72817 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20050143365.pdf [firstpage_image] =>[orig_patent_app_number] => 11069817 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5771869 [patent_doc_number] => 20050267204 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-01 [patent_title] => 'Synergistic gold-containing compositions' [patent_app_type] => utility [patent_app_number] => 11/069083 [patent_app_country] => US [patent_app_date] => 2005-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7578 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20050267204.pdf [firstpage_image] =>[orig_patent_app_number] => 11069083 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4652179 [patent_doc_number] => 20080039435 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-14 [patent_title] => 'Novel Steroid Agonist For Fxr' [patent_app_type] => utility [patent_app_number] => 10/590848 [patent_app_country] => US [patent_app_date] => 2005-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4325 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20080039435.pdf [firstpage_image] =>[orig_patent_app_number] => 10590848 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7075290 [patent_doc_number] => 20050148558 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-07 [patent_title] => 'Stabilized hydroxyvitamin D' [patent_app_type] => utility [patent_app_number] => 11/065429 [patent_app_country] => US [patent_app_date] => 2005-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4952 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20050148558.pdf [firstpage_image] =>[orig_patent_app_number] => 11065429 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7256485 [patent_doc_number] => 20050143364 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-30 [patent_title] => '21-Substituted progesterone derivatives as new antiprogestational agents' [patent_app_type] => utility [patent_app_number] => 11/065632 [patent_app_country] => US [patent_app_date] => 2005-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 22801 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20050143364.pdf [firstpage_image] =>[orig_patent_app_number] => 11065632 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5120630 [patent_doc_number] => 20070142345 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-21 [patent_title] => 'Steroids for cancer treatment' [patent_app_type] => utility [patent_app_number] => 10/587561 [patent_app_country] => US [patent_app_date] => 2005-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21474 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20070142345.pdf [firstpage_image] =>[orig_patent_app_number] => 10587561 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7005762 [patent_doc_number] => 20050171075 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-04 [patent_title] => 'Steroid compounds with a c17-alkyl side chain and an aromatic a-ring for use in therapy' [patent_app_type] => utility [patent_app_number] => 11/055620 [patent_app_country] => US [patent_app_date] => 2005-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18406 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20050171075.pdf [firstpage_image] =>[orig_patent_app_number] => 11055620 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 720175 [patent_doc_number] => 07049305 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-05-23 [patent_title] => 'Bile-acid conjugates providing for sustained systemic concentration of drugs' [patent_app_type] => utility [patent_app_number] => 11/053324 [patent_app_country] => US [patent_app_date] => 2005-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 23016 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/049/07049305.pdf [firstpage_image] =>[orig_patent_app_number] => 11053324 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7224518 [patent_doc_number] => 20050261261 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-24 [patent_title] => 'Eplerenone drug substance having high phase purity' [patent_app_type] => utility [patent_app_number] => 11/051460 [patent_app_country] => US [patent_app_date] => 2005-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 91 [patent_figures_cnt] => 91 [patent_no_of_words] => 25021 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20050261261.pdf [firstpage_image] =>[orig_patent_app_number] => 11051460 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7020083 [patent_doc_number] => 20050222102 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-06 [patent_title] => 'Treatment of rhinitis with anticholinergics alone or in combination with antihistamines, phosphodiesterase 4 inhibitors, or corticosteroids' [patent_app_type] => utility [patent_app_number] => 11/051470 [patent_app_country] => US [patent_app_date] => 2005-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4883 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20050222102.pdf [firstpage_image] =>[orig_patent_app_number] => 11051470 [rel_patent_id] =>[rel_patent_doc_number] =>)